Mary Logue, MD
Dermatology · Minot, NDNPI 1336671445
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,750 of the $8,936 with a category attached, or 86.7%. Eli Lilly accounts for 86.7% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $7,956, more than ten times the $284 reported in 2019. Among dermatology clinicians in ND with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 45 payments — averaging $198.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$8K
- Lilly USA, LLC$533
- AbbVie$338
- Regeneron Healthcare Solutions, Inc.$100
- Bristol Myers Squibb$89
- Novartis$72
- plus $54 from 3 others
What the payments were for
- Consulting fees$7,75087%
- Food & beverage$1,18613%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 3 | $7,750 |
| Lilly USA, LLC | 16 | $533 |
| AbbVie(2 entities) | 12 | $338 |
| Regeneron Healthcare Solutions, Inc. | 3 | $100 |
| Bristol Myers Squibb | 5 | $89 |
| Novartis | 3 | $72 |
| Sanofi | 1 | $22 |
| Pfizer | 1 | $17 |
| Amgen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OLUMIANT$4,750
How this compares
$8,936 in reported general payments places this provider in the 90th percentile of 29 dermatology providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 11 | $42,053 |
| Fluorouracil | 31 | $2,051 |
| Triamcinolone Acetonide | 108 | $1,796 |
| Clobetasol Propionate | 41 | $1,700 |
| Tacrolimus | 13 | $1,020 |
| Doxycycline Monohydrate | 36 | $936 |
| Ketoconazole | 57 | $805 |
| Betamethasone Dipropionate | 19 | $593 |
| Dutasteride | 39 | $465 |
| Hydroxyzine Hcl | 53 | $244 |
| Prednisone | 11 | $69 |
| MethotrexateMethotrexate Sodium | 11 | $63 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Minot
- Margaret NewsomeMinot$8K
- Imran AslamBismarck$280K
- Michael BlankinshipFargo$130K
- Rachel NessFargo$8K
- Alexandra GeigerBismarck$4K
- Nicole SotoBismarck$4K
- Megan StrandBismark$3K
- Amanda BeehlerFargo$2K
- Natalie KollmanFargo$2K
- Joseph EbertzBismarck$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.